Condition
Myeloid Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Myeloid Leukemia clinical trials that are recruiting, at sites in 3 countries (most in United States (5), China (1), Canada (1)). By phase: Phase 2 (2), Phase 1 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Myeloid Leukemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| See if a behavioral coaching plus at-home exercise can help older blood cancer survivors slow aging | — | Omaha, Nebraska | Recruiting | Dec 18, 2025 |
| Using Mitoxantrone for Treating Venetoclax Resistant Acute Myeloid Leukemia | Phase 1 | Aurora, Colorado | Recruiting | May 28, 2024 |
| Combining Gilteritinib and Momelotinib for FLT3-Mutated Acute Myeloid Leukemia | Phase 1/2 | Houston, Texas | Recruiting | Feb 1, 2024 |
| Using interferon-α to prevent relapse in myeloid malignancies after stem cell transplantation | Phase 2 | Beijing, Beijing Municipality | Recruiting | Nov 14, 2023 |
| Exercise and NAD+ Supplementation for Young Cancer Survivors | Phase 2 | Duarte, California and 2 other locations | Recruiting | Jan 18, 2022 |
| Evaluating HQP1351 for patients with resistant leukemia | Phase 1 | Birmingham, Alabama and 8 other locations | Recruiting | Feb 7, 2020 |
All recruiting trials (6)
-
See if a behavioral coaching plus at-home exercise can help older blood cancer survivors slow aging
Aimed at people 50 and older who have had a blood cancer, this trial tests whether combining coaching with a virtual exercise program can help slow aging and improve health.
-
Using Mitoxantrone for Treating Venetoclax Resistant Acute Myeloid Leukemia
This study is testing if a combination of mitoxantrone, venetoclax, and azacitidine can help people with acute myeloid leukemia who haven't responded to previous treatments.
-
Combining Gilteritinib and Momelotinib for FLT3-Mutated Acute Myeloid Leukemia
This study is testing a new combination of two drugs, gilteritinib and momelotinib, to see if they can safely help adults with a specific type of leukemia that hasn't responded to other treatments.
-
Using interferon-α to prevent relapse in myeloid malignancies after stem cell transplantation
This study is testing if a treatment called interferon-α can help prevent relapse in patients with acute myeloid leukemia or myelodysplastic syndrome who have a specific gene mutation and are in remission after a stem cell transplant.
-
Exercise and NAD+ Supplementation for Young Cancer Survivors
This study is testing if combining exercise with a supplement called nicotinamide riboside can help young cancer survivors improve their muscle strength and fitness.
-
Evaluating HQP1351 for patients with resistant leukemia
This study is testing a new drug called HQP1351 to see if it can help patients with resistant chronic myeloid leukemia or Philadelphia positive acute lymphoblastic leukemia feel better and respond to treatment.
Related topics
Quick answers
How many Myeloid Leukemia clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (5 trials), China (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.